Health Systems Need to Use the New Tools to Address RSV, a Leading Cause of Baby Hospitalisations 02/12/2024 Susan Hepworth & Leyla Kragten-Tabatabaie From being a largely unknown pathogen, Respiratory Syncytial Virus (RSV) is now almost a household word – and a fearful one for families with infants and young children at risk. But new solutions, such as long-acting monoclonal antibodies (mAbs) and maternal vaccination, both recently recommended by the World Health Organization (WHO), could dramatically alter the […] Continue reading ->